Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://shaniaggqh246180.activoblog.com/47234963/trelaglutide-exploring-a-new-therapy-for-chronic-diseases